P388: PREFERENTIAL SYNERGISTIC EFFECT OF INDISULAM IN COMBINATION WITH VENETOCLAX AND AZACYTIDINE IN AML CELLS WITH SF3B1 MUTATIONS.
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000844440.63033.80 |
_version_ | 1797281785401311232 |
---|---|
author | P. Bernardo M. Pereira B. Galvão J. Desterro A. Nunes M. D. J. Frade J. Lobato M. G. da Silva M. Lemos M. Silva P. Ribeiro S. Matos N. Custódio M. Carmo-Fonseca |
author_facet | P. Bernardo M. Pereira B. Galvão J. Desterro A. Nunes M. D. J. Frade J. Lobato M. G. da Silva M. Lemos M. Silva P. Ribeiro S. Matos N. Custódio M. Carmo-Fonseca |
author_sort | P. Bernardo |
collection | DOAJ |
first_indexed | 2024-03-07T17:02:27Z |
format | Article |
id | doaj.art-f28f5b23678342969297c72a5220bca7 |
institution | Directory Open Access Journal |
issn | 2572-9241 |
language | English |
last_indexed | 2024-03-07T17:02:27Z |
publishDate | 2022-06-01 |
publisher | Wiley |
record_format | Article |
series | HemaSphere |
spelling | doaj.art-f28f5b23678342969297c72a5220bca72024-03-03T03:19:23ZengWileyHemaSphere2572-92412022-06-01628828910.1097/01.HS9.0000844440.63033.80202206003-00288P388: PREFERENTIAL SYNERGISTIC EFFECT OF INDISULAM IN COMBINATION WITH VENETOCLAX AND AZACYTIDINE IN AML CELLS WITH SF3B1 MUTATIONS.P. Bernardo0M. Pereira1B. Galvão2J. Desterro3A. Nunes4M. D. J. Frade5J. Lobato6M. G. da Silva7M. Lemos8M. Silva9P. Ribeiro10S. Matos11N. Custódio12M. Carmo-Fonseca131 Instituto Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa1 Instituto Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa1 Instituto Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa1 Instituto Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa3 Serviço de Hematologia Clínica, Instituto Português de Oncologia de Lisboa Francisco Gentil3 Serviço de Hematologia Clínica, Instituto Português de Oncologia de Lisboa Francisco Gentil3 Serviço de Hematologia Clínica, Instituto Português de Oncologia de Lisboa Francisco Gentil3 Serviço de Hematologia Clínica, Instituto Português de Oncologia de Lisboa Francisco Gentil4 Serviço de Hematologia Clínica, Centro Hospitalar Lisboa Central - Hospital de St. António dos Capuchos4 Serviço de Hematologia Clínica, Centro Hospitalar Lisboa Central - Hospital de St. António dos Capuchos4 Serviço de Hematologia Clínica, Centro Hospitalar Lisboa Central - Hospital de St. António dos Capuchos5 GenoMed - Diagnósticos de Medicina Molecular SA, Lisbon, Portugal1 Instituto Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa1 Instituto Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboahttp://journals.lww.com/10.1097/01.HS9.0000844440.63033.80 |
spellingShingle | P. Bernardo M. Pereira B. Galvão J. Desterro A. Nunes M. D. J. Frade J. Lobato M. G. da Silva M. Lemos M. Silva P. Ribeiro S. Matos N. Custódio M. Carmo-Fonseca P388: PREFERENTIAL SYNERGISTIC EFFECT OF INDISULAM IN COMBINATION WITH VENETOCLAX AND AZACYTIDINE IN AML CELLS WITH SF3B1 MUTATIONS. HemaSphere |
title | P388: PREFERENTIAL SYNERGISTIC EFFECT OF INDISULAM IN COMBINATION WITH VENETOCLAX AND AZACYTIDINE IN AML CELLS WITH SF3B1 MUTATIONS. |
title_full | P388: PREFERENTIAL SYNERGISTIC EFFECT OF INDISULAM IN COMBINATION WITH VENETOCLAX AND AZACYTIDINE IN AML CELLS WITH SF3B1 MUTATIONS. |
title_fullStr | P388: PREFERENTIAL SYNERGISTIC EFFECT OF INDISULAM IN COMBINATION WITH VENETOCLAX AND AZACYTIDINE IN AML CELLS WITH SF3B1 MUTATIONS. |
title_full_unstemmed | P388: PREFERENTIAL SYNERGISTIC EFFECT OF INDISULAM IN COMBINATION WITH VENETOCLAX AND AZACYTIDINE IN AML CELLS WITH SF3B1 MUTATIONS. |
title_short | P388: PREFERENTIAL SYNERGISTIC EFFECT OF INDISULAM IN COMBINATION WITH VENETOCLAX AND AZACYTIDINE IN AML CELLS WITH SF3B1 MUTATIONS. |
title_sort | p388 preferential synergistic effect of indisulam in combination with venetoclax and azacytidine in aml cells with sf3b1 mutations |
url | http://journals.lww.com/10.1097/01.HS9.0000844440.63033.80 |
work_keys_str_mv | AT pbernardo p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations AT mpereira p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations AT bgalvao p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations AT jdesterro p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations AT anunes p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations AT mdjfrade p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations AT jlobato p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations AT mgdasilva p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations AT mlemos p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations AT msilva p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations AT pribeiro p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations AT smatos p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations AT ncustodio p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations AT mcarmofonseca p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations |